Evidence map›Paper›PMID 34834518›Full record

ReviewJournal of personalized medicine2021

Virtual Reality-Based Therapy Reduces the Disabling Impact of Fibromyalgia Syndrome in Women: Systematic Review with Meta-Analysis of Randomized Controlled Trials.

Irene Cortés-Pérez, Noelia Zagalaz-Anula, María Del Rocío Ibancos-Losada, Francisco Antonio Nieto-Escámez, Esteban Obrero-Gaitán, María Catalina Osuna-Pérez

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of personalized medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 9 pooled it
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 9 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. NintendoInternational journal of environmental research and public health · 2022
    Pooled it
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Irene Cortés-PérezGranada Northeast Health District, Andalusian Health Service, Street San Miguel 2, 18500 Guadix, Spain.ORCID 0000-0002-1876-1399
Noelia Zagalaz-AnulaDepartment of Health Sciences, University of Jaén, Campus Las Lagunillas s/n, 23071 Jaén, Spain.ORCID 0000-0002-7105-9865
María Del Rocío Ibancos-LosadaDepartment of Health Sciences, University of Jaén, Campus Las Lagunillas s/n, 23071 Jaén, Spain.ORCID 0000-0001-6233-1786
Francisco Antonio Nieto-EscámezDepartment of Psychology, University of Almería, Ctra. Sacramento s/n, 04120 Almería, Spain.ORCID 0000-0001-5301-9475
Esteban Obrero-GaitánDepartment of Health Sciences, University of Jaén, Campus Las Lagunillas s/n, 23071 Jaén, Spain.ORCID 0000-0002-8430-5500
María Catalina Osuna-PérezDepartment of Health Sciences, University of Jaén, Campus Las Lagunillas s/n, 23071 Jaén, Spain.ORCID 0000-0003-1293-2983
Universidad de Jaén · ESAndalusian Health Service · ESUniversity of Almería · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVirtual reality-based therapy (VRBT) is a novel therapeutic approach to be used in women with fibromyalgia syndrome (FMS). The aim of our study is to assess the effect of VRBT to reduce the impact of FMS in outcomes such as pain, dynamic balance, aerobic capacity, fatigue, quality of life (QoL), anxiety and depression.

methodsSystematic review with meta-analysis was conducted from a bibliographic search in PubMed, Scopus, PEDro, Web of Science and CINAHL until April 2021 in accordance with PRISMA guidelines. We included randomized controlled trials (RCTs) that compare VRBT versus others to assess the mentioned outcomes in women with FMS. Effect size was calculated with standardized mean difference (SMD) and its 95% confidence interval (95% CI).

resultsEleven RCTs involving 535 women with FMS were included. Using the PEDro scale, the mean methodological quality of the included studies was moderate (6.63 ± 0.51). Our findings showed an effect of VRBT on the impact of FMS (SMD -0.62, 95% CI -0.93 to -0.31); pain (SMD -0.45, 95% CI -0.69 to -0.21); dynamic balance (SMD -0.76, 95% CI -1.12 to -0.39); aerobic capacity (SMD 0.32, 95% CI 0.004 to 0.63); fatigue (SMD -0.58, 95% CI -1.02 to -0.14); QoL (SMD 0.55, 95% CI 0.3 to 0.81); anxiety (SMD -0.47, 95% CI -0.91 to -0.03) and depression (SMD -0.46, 95% CI -0.76 to -0.16).

conclusionsVRBT is an effective therapy that reduces the impact of FMS, pain, fatigue, anxiety and depression and increases dynamic balance, aerobic capacity and quality of life in women with FMS. In addition, VRBT in combination with CTBTE showed a large effect in reducing the impact of FMS and fatigue and increasing QoL in these women.

Indexed as

fatiguefibromyalgiameta-analysispainphysiotherapyquality of lifevirtual reality

Identifiers

PMID34834518
PMCPMC8621064
OpenAlexW3214714125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.